Therefore, when performing fluorescence-guided surgery based on the SPARC target ICG-HSA complex in malignant brain tumors, it is expected to be a promising solution for surgeons by making it possible to identify the SPARC-positive region of cancer. This evidence concerns the gene ALB and brain neoplasm.